BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 18309018)

  • 1. Transcatheter intraarterial perfusion: MR monitoring of chemoembolization for hepatocellular carcinoma--feasibility of initial clinical translation.
    Larson AC; Wang D; Atassi B; Sato KT; Ryu RK; Lewandowski RJ; Nemcek AA; Mulcahy MF; Kulik LM; Miller FH; Salem R; Omary RA
    Radiology; 2008 Mar; 246(3):964-71. PubMed ID: 18309018
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MR imaging perfusion mismatch: a technique to verify successful targeting of liver tumors during transcatheter arterial chemoembolization.
    Lewandowski RJ; Tepper J; Wang D; Ibrahim S; Miller FH; Kulik L; Mulcahy M; Ryu RK; Sato K; Larson AC; Salem R; Omary RA
    J Vasc Interv Radiol; 2008 May; 19(5):698-705. PubMed ID: 18440458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Locoregional chemoembolic delivery: prediction with transcatheter intraarterial perfusion MRI.
    Gaba RC; Jin B; Wang D; Lewandowski RJ; Ragin AB; Larson AC; Salem R; Omary RA
    AJR Am J Roentgenol; 2012 May; 198(5):1196-202. PubMed ID: 22528913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four-dimensional transcatheter intraarterial perfusion MR imaging for monitoring chemoembolization of hepatocellular carcinoma: preliminary results.
    Gaba RC; Wang D; Lewandowski RJ; Ryu RK; Sato KT; Kulik LM; Mulcahy MF; Larson AC; Salem R; Omary RA
    J Vasc Interv Radiol; 2008 Nov; 19(11):1589-95. PubMed ID: 18818097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Perfusion reduction at transcatheter intraarterial perfusion MR imaging: a promising intraprocedural biomarker to predict transplant-free survival during chemoembolization of hepatocellular carcinoma.
    Wang D; Gaba RC; Jin B; Lewandowski RJ; Riaz A; Memon K; Ryu RK; Sato KT; Kulik LM; Mulcahy MF; Larson AC; Salem R; Omary RA
    Radiology; 2014 Aug; 272(2):587-97. PubMed ID: 24678859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative 4D transcatheter intraarterial perfusion MRI for monitoring chemoembolization of hepatocellular carcinoma.
    Wang D; Jin B; Lewandowski RJ; Ryu RK; Sato KT; Mulcahy MF; Kulik LM; Miller FH; Salem R; Li D; Omary RA; Larson AC
    J Magn Reson Imaging; 2010 May; 31(5):1106-16. PubMed ID: 20432345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraprocedural transcatheter intra-arterial perfusion MRI as a predictor of tumor response to chemoembolization for hepatocellular carcinoma.
    Wang D; Gaba RC; Jin B; Riaz A; Lewandowski RJ; Ryu RK; Sato KT; Ragin AB; Kulik LM; Mulcahy MF; Salem R; Larson AC; Omary RA
    Acad Radiol; 2011 Jul; 18(7):828-36. PubMed ID: 21669349
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early response of hepatocellular carcinoma to transcatheter arterial chemoembolization: choline levels and MR diffusion constants--initial experience.
    Chen CY; Li CW; Kuo YT; Jaw TS; Wu DK; Jao JC; Hsu JS; Liu GC
    Radiology; 2006 May; 239(2):448-56. PubMed ID: 16569781
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Superselective Chemoembolization of HCC: Comparison of Short-term Safety and Efficacy between Drug-eluting LC Beads, QuadraSpheres, and Conventional Ethiodized Oil Emulsion.
    Duan F; Wang EQ; Lam MG; Abdelmaksoud MH; Louie JD; Hwang GL; Kothary N; Kuo WT; Hofmann LV; Sze DY
    Radiology; 2016 Feb; 278(2):612-21. PubMed ID: 26334787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Using intravoxel incoherent motion (IVIM) MR imaging to predict lipiodol uptake in patients with hepatocellular carcinoma following transcatheter arterial chemoembolization: a preliminary result.
    Park YS; Lee CH; Kim JH; Kim IS; Kiefer B; Seo TS; Kim KA; Park CM
    Magn Reson Imaging; 2014 Jul; 32(6):638-46. PubMed ID: 24703575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of early imaging response after chemoembolization of hepatocellular carcinoma by phosphorus-31 magnetic resonance spectroscopy-initial experience.
    Yuan Z; Ye XD; Dong S; Xu LC; Xiao XS
    J Vasc Interv Radiol; 2011 Aug; 22(8):1166-73. PubMed ID: 21703872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical application of 320-detector row CT in transcatheter arterial chemoembolization (TACE) for hepatocellular carcinoma.
    Du F; Jiang R; Gu M; He C; Guan J
    Radiol Med; 2015 Aug; 120(8):690-4. PubMed ID: 25698303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo proton magnetic resonance spectroscopy of large focal hepatic lesions and metabolite change of hepatocellular carcinoma before and after transcatheter arterial chemoembolization using 3.0-T MR scanner.
    Kuo YT; Li CW; Chen CY; Jao J; Wu DK; Liu GC
    J Magn Reson Imaging; 2004 May; 19(5):598-604. PubMed ID: 15112309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic arterial chemoembolization for hepatocellular carcinoma: comparison of survival rates with different embolic agents.
    Brown DB; Pilgram TK; Darcy MD; Fundakowski CE; Lisker-Melman M; Chapman WC; Crippin JS
    J Vasc Interv Radiol; 2005 Dec; 16(12):1661-6. PubMed ID: 16371533
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Advanced-stage hepatocellular carcinoma: transarterial chemoembolization versus sorafenib.
    Pinter M; Hucke F; Graziadei I; Vogel W; Maieron A; Königsberg R; Stauber R; Grünberger B; Müller C; Kölblinger C; Peck-Radosavljevic M; Sieghart W
    Radiology; 2012 May; 263(2):590-9. PubMed ID: 22438359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparison of chemoembolization endpoints using angiographic versus transcatheter intraarterial perfusion/MR imaging monitoring.
    Lewandowski RJ; Wang D; Gehl J; Atassi B; Ryu RK; Sato K; Nemcek AA; Miller FH; Mulcahy MF; Kulik L; Larson AC; Salem R; Omary RA
    J Vasc Interv Radiol; 2007 Oct; 18(10):1249-57. PubMed ID: 17911515
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluating the therapeutic effect of hepatocellular carcinoma treated with transcatheter arterial chemoembolization by magnetic resonance perfusion imaging.
    Chen X; Xiao E; Shu D; Yang C; Liang B; He Z; Bian D
    Eur J Gastroenterol Hepatol; 2014 Jan; 26(1):109-13. PubMed ID: 24284371
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Triple-drug transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma: assessment of survival in 124 consecutive patients.
    Gomes AS; Rosove MH; Rosen PJ; Amado RG; Sayre JW; Monteleone PA; Busuttil RW
    AJR Am J Roentgenol; 2009 Dec; 193(6):1665-71. PubMed ID: 19933662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-arterial interleukin-12 gene delivery combined with chemoembolization: anti-tumor effect in a rabbit hepatocellular carcinoma (HCC) model.
    Xia X; Li X; Feng G; Zheng C; Liang H; Zhou G
    Acta Radiol; 2013 Jul; 54(6):684-9. PubMed ID: 23507934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transarterial chemoembolization for hepatocellular carcinoma after transjugular intrahepatic portosystemic shunt.
    Kang JW; Kim JH; Ko GY; Gwon DI; Yoon HK; Sung KB
    Acta Radiol; 2012 Jun; 53(5):545-50. PubMed ID: 22547388
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.